upadacitinib

upadacitinib
Trade Name
Orphan Indication Still’s disease
USA Market Approval USA
USA Designation Date 2017-08-16 00:00:00
Sponsor AbbVie, Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064